Showing results (11-20 of 709) with videos related to
Sort By:
Pageof 71
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian CancerAntonia Digklia, George Coukos, Krisztian HomicskoFrontiers in Immunology|July 23, 2020
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More PersonalValentina Bianchi, Alexandre Harari, George CoukosNature Reviews. Immunology|June 27, 2025
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapyEvripidis Lanitis, Melita Irving, George CoukosOncoimmunology|July 4, 2012
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?Andrea Facciabene, Stephen Santoro, George CoukosMethods in Molecular Biology (Clifton, N.J.)|December 7, 2011
miRNAs in human cancerXiaomin Zhong, George Coukos, Lin ZhangClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2019
Tumor Landscapes: β-Catenin Drives Immune DesertificationDenarda Dangaj, David Barras, George CoukosCurrent Opinion in Immunology|February 11, 2015
Targeting the tumor vasculature to enhance T cell activityEvripidis Lanitis, Melita Irving, George CoukosAmerican Journal of Obstetrics and Gynecology|April 23, 2005
The fibronectin receptor alpha5 integrin subunit is upregulated by cell-cell adhesion via a cyclic AMP-dependent mechanism: implications for human trophoblast migrationChristos Coutifaris, Akinyinka Omigbodun, George CoukosBiomarkers in Medicine|August 18, 2009
Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?Dimitra Sasaroli, George Coukos, Nathalie SchollerPageof 71